BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16336536)

  • 1. Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states.
    Toll A; Gallardo F; Abella ME; Fontcuberta J; Barranco C; Pujol RM
    Int J Dermatol; 2005 Nov; 44(11):964-6. PubMed ID: 16336536
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged therapy with low-molecular-weight heparin after PCI.
    Zidar JP
    J Invasive Cardiol; 2000; 12 Suppl C():7C-10C. PubMed ID: 10762861
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin-induced skin necrosis.
    Nazarian RM; Van Cott EM; Zembowicz A; Duncan LM
    J Am Acad Dermatol; 2009 Aug; 61(2):325-32. PubMed ID: 19615543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin-induced generalized exanthem.
    Kim KH; Lynfield Y
    Cutis; 2003 Jul; 72(1):57-60. PubMed ID: 12889716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enoxaparin induced skin necrosis].
    Scharf Y; Hershkoviz R
    Harefuah; 2003 Nov; 142(11):742-3, 807. PubMed ID: 14631903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence for thrombosis prophylaxis to high-risk patients].
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
    Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of thromboembolic disease in general surgery with clexane (enoxaparin).
    Combe S; Samama MM
    Semin Thromb Hemost; 1991; 17 Suppl 3():291-5. PubMed ID: 1661438
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
    MMW Fortschr Med; 2005 Jun; 147(22):51. PubMed ID: 15977637
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight subcutaneous heparin-induced skin necrosis.
    Montserrat I; Lopez D; Zuazu-Jausoro I; Perez M; de Moragas JM; Fontcuberta J
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):751-2. PubMed ID: 1966800
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin-associated fat necrosis of the breast.
    Das AK
    Age Ageing; 2005 Mar; 34(2):193-4. PubMed ID: 15713870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis.
    Scheja A; Hesselstrand R; Wildt M; Akesson A
    Rheumatology (Oxford); 2007 Dec; 46(12):1862-3. PubMed ID: 17971385
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Antithrombotic management early after mechanical heart valve replacement.
    Hering D; Piper C; Horstkotte D
    J Heart Valve Dis; 2008 May; 17(3):332-4. PubMed ID: 18592931
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic and commercial low molecular weight heparins.
    Messmore HL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):253. PubMed ID: 16959678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.